The Fleming Fund brings evidence and people together to encourage action against drug resistance for a healthier world.

We support low- and middle-income countries to generate, share and use data to improve antimicrobial usage and encourage investment in antimicrobial resistance (AMR).

Gilgit-Baltistan, a region in Pakistan, has faced a high burden of antimicrobial resistance (AMR) across its human, animal, and…

Strong One Health governance provides a coherent framework that brings together the human health, animal health, food safety, and…

Sustainable AMR surveillance for animal health is a One Health challenge for low- and middle-income countries ─ cross-cutting across huma…

Data is a powerful tool in the global effort to tackle antimicrobial resistance (AMR). It transforms disease surveillance into actionable…

26: Active Country Grants
20: Active Regional Grants
321: Supported surveillance sites
30: Countries we work in (more than)
170: National Action Plans developed with Fleming Fund support
155: Countries have supplied data on use of antimicrobial medicines in animals to WOAH database

Since 2017, the Fleming Fund has adopted a comprehensive systems-strengthening approach, investing in laboratory infrastructure, human…

Fleming Fund country grantees completed political economy analyses to inform implementation in phase 2 of the programme, 19 of which are…

This report provides analysis and lessons from implementing the Fleming Fund, drawn from a series of country case studies, to support…

The Fleming Fund was created in 2015-16 to strengthen national AMR surveillance systems in low- and middle-income countries (LMICs) and…